Clicky

Uni-Bio Science Group Ltd(0690)

Description: Uni-Bio Science Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of biological and chemical pharmaceutical products to treat human diseases in the People's Republic of China. The company provides GeneTime, a prescription biological drug for wound healing; GeneSoft, an EGF eye drop for dry eye syndrome, corneal damage, and post-operative healing; Pinup, a voriconazole tablet to treat severe fungal infections; and Bokangtai, a mitiglinide tablet for the treatment of Type 2 diabetes, as well as Boshutai, an oral anti-diabetic drug targeting patients with pre-diabetes condition. It is also developing prescription drugs, including rExendin-4 (Uni-E4) for Type 2 diabetes; and rhPTH 1-34 (Uni-PTH) for the treatment of osteoporosis in postmenopausal women, as well as Uni-GLP, a GLP-1 agonist, a non-insulin treatment candidate for the treatment of Type 2 diabetes. The company was founded in 2001 and is headquartered in Sha Tin, Hong Kong.


Keywords: Diabetes Organ Systems Osteoporosis Endocrine System Peptide Hormones Human Diseases Glucagon Like Peptide 1 Anti Diabetic Drugs Treatment Of Osteoporosis Dry Eye Syndrome Anti Diabetic Medication Drug Targeting Glucagon Like Peptide 1 Receptor Agonist Mitiglinide

Home Page: www.uni-bioscience.com

No. 20 Science Park East Avenue
Sha Tin,
Hong Kong
Phone: 852 3102 3232


Officers

Name Title
Mr. Kingsley Leung AHKIoD, CFA, MSc Exec. Chairman
Mr. Zhi Gang Zhao CPA, MSc CEO & Exec. Director
Mr. Dawei Chen EMBA Exec. Vice Chairman
Mr. Du Kai Financial Controller
Ms. Wei Tian Head of HR & Admin. Department
Mr. Wen Du An Head of Marketing & Sales
Dr. Ya Lei Wen Head of Manufacture Department
Mr. HuaNan Zhao Head of Medical & Regulatory Affairs
Ms. Jing Li Head of R&D Department
Ms. Wing Yan Ho A.C.I.S., A.C.S., ACIS, ACS (PE), ACS(PE), P.E. Company Sec.

Exchange: HK

Country: HK

Currency: Hong Kong Dollar (HK$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.9381
Price-to-Sales TTM: 0.8768
IPO Date: 2001-11-12
Fiscal Year End: December
Full Time Employees: 340
Back to stocks